An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
CNN.com – RSS Channel – Health
Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials
November 26, 2022By
U.S. jury fails to reach verdict in latest J&J talc trial
May 26, 2018By
NEW YORK (Reuters) – A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson’s Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.
